Anterios

Research-based biopharmaceutical company discovering and delivering innovative medicines

placeNew York City, New York, United States calendar_todayFounded 2006 groups8 employees language anteriosinc.com

Registered entities

Innovation

14 patent families (9 granted) — focus: Human necessities; filing pace slowing. Cited 3,638 times.

YearFilings
201411
20156
20167
20178
20185
20195
20205
20214
20222
20231
20241
20252

Investor mix

7 investors on record; lead investors include Ascent Biomedical Ventures, DRW Trading Group, Praesideo Management, Quantum Technology Partners; 2 have since exited.

Investor typeCountShare
Venture capital343%
Private equity229%
Other / undisclosed229%
Coming soon